KANAZAWA; Takanori
Patent Applications and Registrations
Patent applications and USPTO patent grants for KANAZAWA; Takanori.The latest application filed is for "drug delivery composition and pharmaceutical composition".
- KANAZAWA; Takanori - Shizuoka-shi Shizuoka
- Kanazawa; Takanori - Hachioji JP
- Kanazawa; Takanori - Tsukuba JP
- Kanazawa; Takanori - Tokyo JP
- Kanazawa; Takanori - Ibaraki JP
- Kanazawa; Takanori - Tsukuba-shi JP
- Kanazawa; Takanori - Ibaraki Pref JP
| Patent | Date |
|---|---|
| Drug Delivery Composition And Pharmaceutical Composition App 20220241422 - KANAZAWA; Takanori ; et al. | 2022-08-04 |
| Composition for delivering nucleic acid and nucleic acid-containing composition Grant 11,345,914 - Kanazawa , et al. May 31, 2 | 2022-05-31 |
| Nucleic Acid Delivery Composition, And Nucleic Acid-containing Composition App 20210115440 - KANAZAWA; Takanori ; et al. | 2021-04-22 |
| Pyrimidine derivatives Grant 8,263,590 - Garcia-Echeverria , et al. September 11, 2 | 2012-09-11 |
| Organic compounds Grant 8,178,559 - Breitenstein , et al. May 15, 2 | 2012-05-15 |
| Organic compounds Grant 8,163,773 - Breitenstein , et al. April 24, 2 | 2012-04-24 |
| Organic compounds Grant 8,129,411 - Ehara , et al. March 6, 2 | 2012-03-06 |
| Organic compounds Grant 8,084,450 - Breitenstein , et al. December 27, 2 | 2011-12-27 |
| Organic Compounds App 20110263560 - BREITENSTEIN; Werner ; et al. | 2011-10-27 |
| Arylsulfonamido-substituted hydroxamic acid derivatives Grant 8,034,810 - Breitenstein , et al. October 11, 2 | 2011-10-11 |
| Pyrimidine Derivatives App 20110201606 - Garcia-Echeverria; Carlos ; et al. | 2011-08-18 |
| 2,4-di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders Grant 7,964,592 - Garcia-Echeverria , et al. June 21, 2 | 2011-06-21 |
| 2,4-pyrimidinediamines Useful In The Treatment Of Neoplastic Diseases, Inflammatory And Immune System Disorders App 20110098280 - Garcia-Echeverria; Carlos ; et al. | 2011-04-28 |
| 2, 4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders Grant 7,893,074 - Garcia-Echeverria , et al. February 22, 2 | 2011-02-22 |
| 3, 4, 5 - Substituted Piperidine Compounds App 20100160305 - Masuya; Keiichi ; et al. | 2010-06-24 |
| 3,4,(5)-substituted Tetrahydrophyridines App 20100029647 - Masuya; Keiichi ; et al. | 2010-02-04 |
| Organic Compounds App 20090312304 - Breitenstein; Werner ; et al. | 2009-12-17 |
| Organic Compounds App 20090233920 - Breitenstein; Werner ; et al. | 2009-09-17 |
| Organic Compounds App 20090192148 - Ehara; Takeru ; et al. | 2009-07-30 |
| Arylsulfonamido-substituted hydroxamic acid derivatives App 20080275127 - Breitenstein; Werner ; et al. | 2008-11-06 |
| 3-Mono-and 3,5-Disubstituted Piperidine Derivatives as Renin Inhibitors App 20080194629 - Baeschlin; Daniel Kaspar ; et al. | 2008-08-14 |
| 2, 4-Pyrimidinediamines Useful In The Treatment Of Neoplastic Diseases, Inflammatory And Immune System Disorders App 20080132504 - Garcia-Echeverria; Carlos ; et al. | 2008-06-05 |
| Arylsulfonamido-substituted hydroxamic acid derivatives Grant 7,138,432 - Breitenstein , et al. November 21, 2 | 2006-11-21 |
| 2-Cyanopyrrolopyrimidines and pharmaceutical uses thereof App 20060247251 - Buxton; Francis Paul ; et al. | 2006-11-02 |
| 2,4-Di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders App 20060247241 - Garcia-Echeverria; Carlos ; et al. | 2006-11-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 